20.92
Schlusskurs vom Vortag:
$20.90
Offen:
$20.93
24-Stunden-Volumen:
608.83K
Relative Volume:
0.67
Marktkapitalisierung:
$1.32B
Einnahmen:
$384.03M
Nettoeinkommen (Verlust:
$38.65M
KGV:
67.48
EPS:
0.31
Netto-Cashflow:
$196.35M
1W Leistung:
+4.44%
1M Leistung:
+12.53%
6M Leistung:
+19.07%
1J Leistung:
+6.25%
Innoviva Inc Stock (INVA) Company Profile
Firmenname
Innoviva Inc
Sektor
Branche
Telefon
(650) 238-9600
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Vergleichen Sie INVA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
INVA
Innoviva Inc
|
20.92 | 1.32B | 384.03M | 38.65M | 196.35M | 0.31 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-11 | Eingeleitet | Oppenheimer | Outperform |
2025-07-14 | Eingeleitet | H.C. Wainwright | Buy |
2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
2024-06-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
2022-07-20 | Eingeleitet | Goldman | Neutral |
2017-11-20 | Eingeleitet | Deutsche Bank | Hold |
Alle ansehen
Innoviva Inc Aktie (INVA) Neueste Nachrichten
Is Innoviva Inc. still a buy after recent gainsJuly 2025 Gainers & Daily Technical Stock Forecast Reports - khodrobank.com
Does Innoviva Inc. fit your quant trading modelTrade Analysis Report & Expert Verified Stock Movement Alerts - Newser
Is Innoviva Inc. stock technically oversoldJuly 2025 Closing Moves & Safe Investment Capital Preservation Plans - khodrobank.com
Tools to assess Innoviva Inc.’s risk profileDay Trade & Free Weekly Watchlist of Top Performers - Newser
What earnings revisions data tells us about Innoviva Inc.Weekly Market Summary & AI Enhanced Trading Signals - Newser
Risk vs reward if holding onto Innoviva Inc.July 2025 Action & Fast Entry and Exit Trade Plans - Newser
Should you hold or exit Innoviva Inc. nowMarket Movement Recap & Entry Point Confirmation Signals - Newser
How to build a custom watchlist for Innoviva Inc.2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
Is Innoviva Inc. a defensive stock2025 Geopolitical Influence & Weekly Setup with High ROI Potential - khodrobank.com
Can Innoviva Inc. hit a new high this month2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser
Why Innoviva Inc. is moving todayWeekly Trade Summary & AI Enhanced Market Trend Forecasts - Newser
Will Innoviva Inc. price bounce be sustainableWeekly Investment Report & AI Optimized Trade Strategies - Newser
Volume spikes in Innoviva Inc. stock – what they meanJuly 2025 Setups & Expert-Curated Trade Recommendations - Newser
Is it too late to sell Innoviva Inc.Earnings Beat & Proven Capital Preservation Methods - Newser
Is Innoviva Inc. forming a bottoming basePortfolio Growth Summary & Real-Time Market Trend Scan - Newser
Multi asset correlation models including Innoviva Inc.2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Analyzing net buyer seller activity in Innoviva Inc.2025 Short Interest & Community Consensus Picks - Newser
Using fundamentals and technicals on Innoviva Inc.Market Trend Report & Weekly High Conviction Trade Ideas - Newser
Has Innoviva Inc. found a price floor2025 Sector Review & Growth Focused Stock Pick Reports - Newser
Is Innoviva Inc. impacted by rising ratesQuarterly Earnings Report & Weekly Return Optimization Alerts - khodrobank.com
Live market analysis of Innoviva Inc.Market Weekly Review & Fast Exit/Entry Strategy Plans - Newser
Published on: 2025-09-03 02:54:47 - khodrobank.com
Innoviva's CEO Pavel Raifeld Presents at Citi's Biopharma Back to School Conference. - AInvest
How to recover losses in Innoviva Inc. stockWeekly Investment Recap & Step-by-Step Swing Trade Plans - Newser
What does recent volatility data suggest for Innoviva Inc.Portfolio Risk Summary & Stock Portfolio Risk Management - Newser
Will a bounce in Innoviva Inc. offer an exit2025 Trading Recap & Real-Time Chart Breakout Alerts - Newser
Real time breakdown of Innoviva Inc. stock performanceJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - Newser
Sector ETF Data Correlates with Strength in Innoviva Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
What’s next for Innoviva Inc. stockMarket Performance Summary & Low Volatility Stock Recommendations - khodrobank.com
Will Innoviva Inc. benefit from rate cuts2025 Market Outlook & Safe Entry Point Identification - khodrobank.com
Is Innoviva Inc. being accumulated by smart moneyJuly 2025 Sector Moves & Weekly Setup with ROI Potential - khodrobank.com
Sector Leaders Rotate Capital Into Innoviva Inc.2025 Trading Recap & Daily Market Momentum Tracking - beatles.ru
Innoviva Inc. Approaches Psychological Resistance Level getLinesFromResByArray error: size == 0 - kangso.co.kr
Moving Averages: Is Innoviva Inc. stock trending bullishJuly 2025 PreEarnings & Risk Managed Investment Strategies - khodrobank.com
Sector ETF performance correlation with Innoviva Inc.Weekly Market Report & Community Consensus Picks - Newser
Innoviva Inc. Included in Top Momentum Scan getLinesFromResByArray error: size == 0 - newsyoung.net
Bollinger Bands Show Potential Breakout in Innoviva Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Finanzdaten der Innoviva Inc-Aktie (INVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Innoviva Inc-Aktie (INVA) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):